Pharmacodynamics of Cinacalcet Over 48 Hours in Patients With Controlled Secondary Hyperparathyroidism: Useful Data in Clinical Practice | Zendy

María Dolores Arenas | Zendy; Vanesa de la Fuente | Zendy; Pablo Delgado | Zendy; María Teresa Gil | Zendy; Patrícia Gutiérrez | Zendy; Jorge Ribero | Zendy; Mariano Rodríguez | Zendy; Yolanda Almadén | Zendy

Open Access

Pharmacodynamics of Cinacalcet Over 48 Hours in Patients With Controlled Secondary Hyperparathyroidism: Useful Data in Clinical Practice

Author(s) -

María Dolores Arenas,

Vanesa de la Fuente,

Pablo Delgado,

María Teresa Gil,

Patrícia Gutiérrez,

Jorge Ribero,

Mariano Rodríguez,

Yolanda Almadén

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-4003

Subject(s) - cinacalcet , pharmacodynamics , secondary hyperparathyroidism , medicine , clinical practice , hyperparathyroidism , pharmacology , urology , pharmacokinetics , calcium , parathyroid hormone , physical therapy

Cinacalcet induces immediate changes in serum PTH levels, but the pharmacodynamic effect throughout the daily dosing interval in controlled patients is unknown. Also, in patients with reduced PTH, it is unknown what happens in the first 24 hours after withdrawal.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research